In this study, we implemented systematic characterization of STING pathway in SCLC tumors, in which we determined that STING expression was downregulated in SCLC tumors compared to normal lung tissues and identified a STING‐high SCLC subtype associated with increased expression of immune‐related genes and decreased NE score. This evidence concerns the gene STING1 and small cell lung carcinoma.